上機數控(603185.SH)漲停創歷史新高 單晶硅片銷售火爆
格隆匯12月1日丨延續近日強勢,上機數控(603185.SH)今日漲停,報95.38元,股價創歷史新高,市值222億元。上機數控11月29日公告,全資子公司弘元新材與東方日升(常州)進出口有限公司就“單晶硅片”的銷售簽訂合同。未來三年, 弘元新材將向對方提供約113.63億元的單晶硅片。上機數控11月還和天合光能(688599.SH)簽訂了百億長單採購合同。隨着單晶硅片銷售火爆,上機數控今年以來的經營業績大幅增長。前三季度,公司實現營業收入19.47億元,同比增逾3倍。有分析人士稱,如果以當前單晶硅片市場價估算,未來三年,上機數控經營業績將保持高速增長。其中,2021年,其營業收入或將達到50億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.